ASRS
RXRX icon

Arizona State Retirement System’s Recursion Pharmaceuticals RXRX Stock Holding History

Arizona State Retirement System’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$374K Buy
121,706
+20,383
+20% +$78.8K ﹤0.01% 1617
2025
Q4 		$414K Buy
101,323
+6,778
+7% +$33.6K ﹤0.01% 1584
2025
Q3 		$461K Buy
94,545
+8,153
+9% +$42.8K ﹤0.01% 1561
2025
Q2 		$437K Buy
86,392
+14,896
+21% +$73.2K ﹤0.01% 1528
2025
Q1 		$378K Sell
71,496
-239
-0.3% -$1.74K ﹤0.01% 1554
2024
Q4 		$485K Buy
71,735
+19,063
+36% +$128K ﹤0.01% 1491
2024
Q3 		$347K Buy
52,672
+4,981
+10% +$35.7K ﹤0.01% 1689
2024
Q2 		$358K Buy
47,691
+4,760
+11% +$41.5K ﹤0.01% 1615
2024
Q1 		$428K Buy
42,931
+3,005
+8% +$33.5K ﹤0.01% 1531
2023
Q4 		$394K Buy
39,926
+3,125
+8% +$22.3K ﹤0.01% 1588
2023
Q3 		$282K Buy
36,801
+733
+2% +$7.31K ﹤0.01% 1709
2023
Q2 		$269K Buy
36,068
+20,274
+128% +$142K ﹤0.01% 1780
2023
Q1 		$105K Buy
15,794
+1,815
+13% +$14.4K ﹤0.01% 2104
2022
Q4 		$108K Buy
13,979
+622
+5% +$6.1K ﹤0.01% 2094
2022
Q3 		$142K Buy
13,357
+388
+3% +$3.93K ﹤0.01% 2014
2022
Q2 		$106K Buy
12,969
+2,188
+20% +$14.6K ﹤0.01% 2106
2022
Q1 		$77K Buy
10,781
+81
+0.8% +$861 ﹤0.01% 2191
2021
Q4 		$183K Buy
+10,700
New +$201K ﹤0.01% 2106

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arizona State Retirement System's RXRX Position: Q1 2026 in Review

Arizona State Retirement System increased its Recursion Pharmaceuticals (RXRX) stake by 20% in Q1 2026, buying an estimated $78.8K and bringing the position to 121,706 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

Arizona State Retirement System first reported a position in RXRX in Q4 2021 and has held it in 18 quarters since. The position peaked at $485K in Q4 2024. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Arizona State Retirement System held 121,706 shares of Recursion Pharmaceuticals worth $374K as of Q1 2026.
  • Arizona State Retirement System bought 20,383 Recursion Pharmaceuticals shares in Q1 2026, an estimated $78.8K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1617 holding.
  • Arizona State Retirement System first reported a position in Recursion Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Arizona State Retirement System's Recursion Pharmaceuticals position peaked at $485K in Q4 2024.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.